Skip to main content

Lakefront Biotherapeutics

Lakefront Biotherapeutics is an American clinical-stage biotechnology company focused on the discovery and development of novel biological cancer therapeutics. The company concentrates its scientific research on engineering targeted immuno-oncology therapies and specialized biological molecules to treat complex solid tumors. Its drug development pipeline features proprietary monoclonal antibodies and recombinant proteins designed to enhance anti-tumor immune responses. Primary revenue is derived from biopharmaceutical research collaborations, licensing agreements, and upfront milestone payments from development partners. Lakefront Biotherapeutics holds an established position as a specialized oncology drug discovery enterprise. The company is headquartered in the United States.

9 of the funds FundTelligence covers report a position in Lakefront Biotherapeutics.

Sector
Health Care
Country
United States
Funds holding it
9

Funds holding Lakefront Biotherapeutics

Showing the 8 largest of 9 funds holding it.

Loading...